| Particulars |
|
|
|
|
Company Name
| Cohance Lifesciences Ltd
|
Year End
| 202503
|
| Full Year |
| Equity (₹ Cr.) |
38.26 |
B.V. (₹) |
60.90 |
| Sales(₹ Cr.) |
1,093.51 |
NP (₹ Cr.) |
271.71 |
| NP Var% |
0.00 |
Div% |
0.00 |
| CPS(₹) |
8.60 |
EPS (₹) |
7.10 |
| Traded Value(₹ Lakhs) |
42.48 |
52 Week High |
1,359.00 |
| 52 Week Low |
911.00 |
Price BSE |
986.00 |
| Price NSE |
986.00 |
Market Capital (₹ Cr.) |
37,719.21 |
| P/C Ratio |
114.70 |
P/E Ratio |
138.80 |
| Price Vs.BV |
16.19 |
|
| Latest Quarter |
| Year End |
202506 |
Sales (₹ Cr.) |
483.58 |
| NP(₹ Cr.) |
58.56 |
NP Var % |
-22.00 |
| Trailing Twelve Months |
| Year End |
202503 |
Sales |
914.50 |
| OPM |
37.29 |
NP |
247.20 |
| NP Var% |
-0.21 |
EPS |
7.10 |
| PE |
138.87 |
|
|